netFormulary NHS
Lancashire and South Cumbria
Formulary
 Search
 Results

Looking for Aflibercept found 11 matches
Open monograph to display formulary status BNF Category
  Aflibercept  (Eylea®) Eye - Subfoveal choroidal neovascularisation - 11.08.02
  Aflibercept 8mg in 0.07ml inj Eye - Subfoveal choroidal neovascularisation - 11.08.02
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA: EYLEA 40 mg/mL (aflibercept solution for intravitreal injection): Higher risk of intraocular pressure increase with the pre-filled syringe (11.08.02)
link in drug section NICE TA294: Aflibercept solution for injection for treating wet age‑related macular degeneration (11.08.02)
link in drug section NICE TA294: Aflibercept solution for injection for treating wet age‑related macular degeneration (11.08.02)
link in drug section NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion (11.08.02)
link in drug section NICE TA346: Aflibercept for treating diabetic macular oedema (11.08.02)
link in drug section NICE TA346: Aflibercept for treating diabetic macular oedema (11.08.02)
link in drug section NICE TA409: Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion (11.08.02)
link in drug section NICE TA486: Aflibercept for treating choroidal neovascularisation (11.08.02)
link in drug section NICE TSID10590: High-dose aflibercept for treating wet age-related macular degeneration (11.08.02)




Document Library Items Found

 
netFormulary